JiaLiang Medical Honored with BIOHK International Industry Award, Showcasing China's Innovation in Global MedTech
GenLight
Innovative Medical Device Solution Provider
From September 11 to 14, 2024, the highly anticipated annual event in the global biotechnology industry –BIOHK Hong Kong International Biotechnology Forum and ExhibitionGrandly held at the Hong Kong International Convention and Exhibition Center,Top experts, industry leaders, and innovative companies from around the world gathered to discuss breakthroughs in cutting-edge biotechnology and future development opportunities.
During the roadshow session of the conference, Genlight Neurotech showcased its outstanding innovation capabilities and received widespread acclaim, being rated as one of the five most noteworthy companies.
This honor fully demonstrates the recognition from international peers of GenLight's technical strength and innovation capabilities. In the future, the companyWill continue to uphold the concept of innovation as the foundation，With its outstanding R&D capabilities, international perspective, and extensive cooperation with top global medical institutions,Committed to providing safer and more effective neurosurgical solutions for patients worldwidePlan.
About BIOHK
Hong Kong International Biotech Forum and Exhibition (BIOHK) is the leading biotechnology event in the Asia-Pacific region, bringing together top scientists, industry leaders, innovative companies, and investors from around the world. The exhibition covers cutting-edge fields such as precision medicine, gene editing, cell therapy, biopharmaceuticals, medical devices, and artificial intelligence, focusing on promoting technological innovation and clinical applications.
This event not only provides a platform for companies to showcase cutting-edge technologies but also promotes cooperation and development in the global biotech industry through a variety of activities such as high-end forums, technology exhibitions, and investment matchmaking. BIOHK 2024 attracted more than 200 guests and industry leaders from around the world to discuss how to address global health challenges through technological innovation and promote the sustainable development of biotechnology.
About GenLight
Genlight Neurotech was founded in Hangzhou in 2020 as a high-tech platform enterprise dedicated to industrializing cutting-edge technologies in the fields of brain science and neurosurgery.
The company has built three advanced technology platforms: brain-computer modulation, medical lasers, and brain-computer chips, providing innovative device solutions for various neurological disorders. Developed products include a magnetic resonance-guided laser ablation surgery system (LITT) for minimally invasive brain surgeries, an implantable closed-loop self-responsive neurostimulation system for treating epilepsy and Parkinson’s disease, and deep brain electrodes, some of which have entered the formal clinical trial stage.
Genlight Neurotech adheres to the concept of independent innovation and benefiting patients, with a global layout and coordinated development of production and research, striving to become a trusted leader in solutions within the field of neurology.
